BamSEC and AlphaSense Join Forces
Learn More

Medicis Pharmaceutical Corp

Formerly NYSE: MRX
Search in Documents
Key Exhibits
External Links

Indentures Filter

EX-4.3
from 8-K 7 pages Supplemental Indenture Medicis Pharmaceutical Corporation 1.375% Convertible Senior Notes Due 2017 Second Supplemental Indenture Dated as of December 11, 2012 Deutsche Bank Trust Company Americas as Trustee Second Supplemental Indenture
12/34/56
EX-4.2
from 8-K 6 pages Supplemental Indenture Medicis Pharmaceutical Corporation 2.5% Contingent Convertible Senior Notes Due 2032 First Supplemental Indenture Dated as of December 11, 2012 Deutsche Bank Trust Company Americas as Trustee First Supplemental Indenture
12/34/56
EX-4.1
from 8-K 6 pages Supplemental Indenture Medicis Pharmaceutical Corporation 1.5% Contingent Convertible Senior Notes Due 2033 Second Supplemental Indenture Dated as of December 11, 2012 Deutsche Bank Trust Company Americas as Trustee Second Supplemental Indenture
12/34/56
EX-4.2
from 8-K 77 pages Medicis Pharmaceutical Corporation First Supplemental Indenture Dated as of May 16, 2012 to Indenture Dated as of May 16, 2012 Deutsche Bank Trust Company Americas Trustee 1.375% Convertible Senior Notes Due 2017
12/34/56
EX-4.1
from 8-K 50 pages Medicis Pharmaceutical Corporation Indenture Dated as of May 16, 2012 Deutsche Bank Trust Company Americas Trustee
12/34/56
EX-4.3
from S-3ASR 50 pages Medicis Pharmaceutical Corporation Indenture Dated as of , 20 Deutsche Bank Trust Company Americas Trustee
12/34/56
EX-4.1
from 8-K 50 pages Amended and Restated Rights Agreement by and Between Medicis Pharmaceutical Corporation and Wells Fargo Bank, N.A., as Rights Agent Dated as of August 17, 2005
12/34/56
EX-4.1
from 10-Q ~5 pages Indenture or similar
12/34/56
EX-4.1D
from 10-K >50 pages Indenture or similar
12/34/56
EX-4.2
from S-4/A >50 pages Indenture or similar
12/34/56
EX-4
from S-8 ~10 pages Indenture or similar
12/34/56
EX-4
from S-3 ~5 pages Exh. 4.4 (Amendment No.3 to Rights Agreement)
12/34/56
EX-4.2
from 8-K ~20 pages Indenture or similar
12/34/56
EX-4.1
from 8-K >50 pages Indenture or similar
12/34/56
EX-4.1C
from 8-A12B/A 6 pages Amendment No. 3 to Rights Agreement Dated as of May 31, 2002 Between Medicis Pharmaceutical Corporation and Wells Fargo Bank Minnesota, N.A., as Successor-In-Interest to American Stock Transfer & Trust Company, as Rights Agent
12/34/56
EX-4.1B
from 8-A12B/A ~10 pages Indenture or similar
12/34/56
EX-4.1.B
from 10-Q ~10 pages Amendment #2 to Rights Agreement
12/34/56
EX-4.3
from 10-K/A 1 page Form of Specimen Certificate for Class a Common
12/34/56
EX-4
from SC 13D/A 1 page Indenture or similar
12/34/56